Cicada COVID Variant Fuels 15% U.S. Case Spike, Alarms CDC

The Centers for Disease Control and Prevention has flagged a rapid rise in the SARS-CoV-2 BA.3.2 variant, nicknamed 'Cicada' for its pattern of emergence and retreat, now accounting for over 20% of COVID infections in some U.S. wastewater samples.[1][2][6] First detected in South Africa on November 22, 2024, the strain boasts 70 to 75 mutations and deletions in its spike protein compared to dominant lineages like JN.1 and LP.8.1, raising fears of immune escape.[2][3][5] U.S. cases jumped 15% recently, with Cicada detected in nasal swabs from four travelers, clinical samples from five patients, three airplane wastewater samples, and 132 surveillance samples across 25 states.[1][2][3] BA.3.2 entered the U.S. on June 27, 2025, via a traveler from the Netherlands, with the first domestic clinical case on January 5, 2026.[2][3] Detections escalated from less than 4% in mid-March to more than 20% by early April, per Stanford's WasteWaterSCAN data.[1] Globally, it hit 30% of sequences in Denmark, Germany, and the Netherlands from November 2025 to January 2026, and now comprises about 8% worldwide per the World Health Organization.[1][2][4] Despite low overall prevalence at 0.19% of 2,579 U.S. sequences since December 1, 2025, its two sublineages—BA.3.2.1 and BA.3.2.2—signal ongoing evolution.[2][3] Dr. Marc Siegel, Fox News senior medical analyst, called BA.3.2 'concerning' due to its mutations, though hospitalization rates remain stable.[2] CDC researchers stress continued genomic surveillance via wastewater, traveler screening, and national sequencing to track impacts on vaccine efficacy, as spike changes may weaken protection from shots or infections.[2][3][5] Current vaccines target JN.1 descendants, prompting calls for updates if Cicada dominates.[5] Wastewater surveillance shows Cicada at 11% of U.S. samples, up from trace levels, amid a broader 15% case spike.[1][6] Experts like Dr. William Schaffner warn of a possible late-spring or summer wave, similar to past surges.[6] The CDC's modeling dashboard tracks real-time trends, but no new mandates have emerged as flu and RSV wane.[6][7]